WILMINGTON, Mass.--(BUSINESS WIRE)--Aug 30, 2018--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including:

Wells Fargo 2018 Healthcare Conference in Boston on Wednesday, September 5 th, at 9:40 a.m. ET; Baird 2018 Global Healthcare Conference in New York on Thursday, September 6 th, at 10:15 a.m. ET; and Morgan Stanley 16 th Annual Global Healthcare Conference in New York on Thursday, September 13 th, at 10:00 a.m. ET.

Management will provide an overview of Charles River’s strategic focus and business developments.

A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180830005838/en/

CONTACT: Charles River Laboratories International, Inc.

Investor Relations Contact:

Todd Spencer, 781-222-6455

Corporate Vice President, Investor Relations

todd.spencer@crl.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL GENERAL HEALTH

SOURCE: Charles River Laboratories International, Inc.

Copyright Business Wire 2018.

PUB: 08/30/2018 04:37 PM/DISC: 08/30/2018 04:37 PM

http://www.businesswire.com/news/home/20180830005838/en